The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...
Zacks Investment Research on MSN
MRNA stock jumps to 52-week high on expansion plans beyond vaccines
Shares of Moderna MRNA rose nearly 13% on Friday after the company unveiled a long-term strategy to transform itself from a ...
A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...
A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...
Stocktwits on MSN
MRNA stock rallies over 40% in June: Moderna bets its future on cancer, autoimmune disease and AI-powered mRNA
At Science Day, Moderna outlined growth plans across infectious-disease vaccines, Intismeran, and rare-disease therapeutics. ...
The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...
Provides broad overview of Company's research and early development programs expected to continue to fuel future ...
CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma ...
A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of ...
The Food and Drug Administration's top vaccine advisory committee voted Thursday to recommend an mRNA influenza vaccine. It's ...
MedPage Today on MSN
FDA Staff Weigh In on Potential First mRNA Flu Shot
Moderna's novel vaccine was at the center of dustup with agency earlier this year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results